Most Recent
Janssen files lawsuit to block generic version of HIV drug
Drug maker Janssen has fired off a lawsuit against Juno Pharmaceuticals for allegedly threatening to infringe a patent for its HIV drug Prezista with a generic version of the drug, one year after fending off generic competition from a different drug maker.
Burger chain flips, agrees to injunction over Sizzler ‘tribute’ burger  
The Brisbane-based burger chain at the centre of a trademark stoush with buffet bar pioneer Sizzler has agreed to refrain from its allegedly infringing trade mark use until the case is decided.
Tribute burger ‘Sizzler’ comes under fire from restaurant giant
Casual dining pioneer Sizzler has served up a trade mark lawsuit over an eponymous burger sold by a Brisbane-based burger chain and marketed as an "ode to the cultural icon".
Court invalidates Caffitaly coffee capsule patents, tosses infringement case against rival
Coffee capsule machine manufacturer Caffitaly has suffered a significant loss in its intellectual property case against a rival, with the Federal Court dismissing its infringement claims and revoking three of its patents in a single shot.
Australian Bar Association’s trade mark lawsuit is not a class action, judge says
A trade mark infringement lawsuit filed by the former CEO of the Australian Bar Association was not properly brought as a class action on behalf of member barristers, a judge has found.
Full Court deals another blow to software patents in Rokt case
The Full Federal Court has rejected a patent application for a digital advertising system by e-commerce firm Rokt in a test case by IP Australia that comes as a blow to the patentability of computer software in Australia.
Government loses case claiming $325M over generic Plavix delay
A court has dismissed a claim by the Australian Government for $325 million against pharmaceutical companies Sanofi and Bristol-Myers Squibb allegedly owed for excess subsidies it paid for blood-thinner Plavix as a result of an interlocutory injunction blocking a generic version of the blockbuster drug.
Rokt parries blows from Full Court as it looks to save software patent
A landmark ruling granting fintech Rokt's application for a software patent has come under attack before the Full Federal Court, with the judges expressing skepticism about the invention's patentability.
Corrs partner on the hook for security in DNA patent appeal
A partner at Corrs Chambers Westgarth who successfully opposed a genome editing patent by ToolGen, and a corporate predecessor of law firm Ashurst, have been ordered to pay $375,000 in security in an appeal launched by the South Korean biotech firm.
Ousted Piper Alderman partner to expand case against firm
A former senior Piper Alderman partner who lodged a sex discrimination case against the firm and was forced off the partnership in June is broadening her case, a court has heard.